| Serial Number | 97501359 |
| Word Mark | BLUEROCK |
| Filing Date | Wednesday, July 13, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, April 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 19, 2023 |
| Goods and Services | Cells for medical or clinical use; genetic material being cells and biological tissue cultures for medical or clinical use; cell therapy and genetic medicine-based pharmaceutical and therapeutic pharmaceutical preparations for the treatment of Parkinson's disease, cancer, cardiovascular disease, ophthalmological diseases, autoimmune disorders, neurological disorders, lysosomal disorders, central nervous system diseases, gastrointestinal disorders, dermatological disorders, inflammatory diseases, metabolic disorders, respiratory diseases, and endocrine diseases; pharmaceutical and therapeutic pharmaceutical preparations in the nature of cells for human use for treating Parkinson's disease, cancer, cardiovascular disease, ophthalmological diseases, autoimmune disorders, neurological disorders, lysosomal disorders, central nervous system diseases, gastrointestinal disorders, dermatological disorders, inflammatory diseases, metabolic disorders, respiratory diseases, and endocrine diseases through cell therapy or gene therapy; cell therapy and genetic medicine-based pharmaceutical preparations for the treatment of Parkinson's disease, cancer, cardiovascular disease, ophthalmological diseases, autoimmune disorders, neurological disorders, lysosomal disorders, central nervous system diseases, gastrointestinal disorders, dermatological disorders, inflammatory diseases, metabolic disorders, respiratory diseases, and endocrine diseases through gene therapy and cell therapy |
| Pseudo Mark | BLUE ROCK |
| Goods and Services | Medical treatment of Parkinson's disease, cancer, cardiovascular disease, ophthalmological diseases, autoimmune disorders, neurological disorders, lysosomal disorders, central nervous system diseases, gastrointestinal disorders, dermatological disorders, inflammatory diseases, metabolic disorders, respiratory diseases, and endocrine diseases; collection and preservation of human biological tissue, blood and cells for medical diagnostic testing purposes; medical diagnostic testing, monitoring and reporting services |
| Goods and Services | Medical and scientific research services in the fields of gene therapy and cell therapy; pharmaceutical research and development services |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 052, 051, 005, 018, 006, 044, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 2, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 2, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 2, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BlueRock Therapeutics LP |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 13 - Limited Partnership |
| Address | Cambridge, MA 02142 |
| Party Name | BlueRock Therapeutics LP |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 13 - Limited Partnership |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Friday, April 12, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, April 11, 2024 | SOU EXTENSION 1 GRANTED |
| Thursday, April 11, 2024 | SOU EXTENSION 1 FILED |
| Thursday, April 11, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 14, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, October 12, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, October 12, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, October 12, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, October 3, 2023 | WITHDRAWAL OF ATTORNEY GRANTED |
| Tuesday, October 3, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| Tuesday, September 19, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 19, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 30, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, August 25, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, August 25, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, August 25, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, August 15, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 15, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 15, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 15, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 15, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, July 31, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 28, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 28, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, April 28, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, April 28, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, April 28, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, April 27, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, August 2, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, July 16, 2022 | NEW APPLICATION ENTERED |